Smith Group Asset Management LLC acquired a new stake in shares of MetLife, Inc. (NYSE:MET - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 30,000 shares of the financial services provider's stock, valued at approximately $2,456,000.
Other institutional investors also recently added to or reduced their stakes in the company. MeadowBrook Investment Advisors LLC boosted its holdings in shares of MetLife by 244.4% in the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider's stock worth $26,000 after acquiring an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. boosted its holdings in shares of MetLife by 131.9% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider's stock worth $27,000 after acquiring an additional 186 shares in the last quarter. Wolff Wiese Magana LLC boosted its holdings in shares of MetLife by 374.3% in the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider's stock worth $29,000 after acquiring an additional 277 shares in the last quarter. Peterson Financial Group Inc. acquired a new position in shares of MetLife in the 3rd quarter worth approximately $30,000. Finally, Retirement Wealth Solutions LLC acquired a new position in shares of MetLife in the 4th quarter worth approximately $32,000. 94.99% of the stock is owned by institutional investors and hedge funds.
MetLife Stock Down 0.5 %
MET stock traded down $0.44 during trading hours on Friday, reaching $86.56. 2,992,769 shares of the stock were exchanged, compared to its average volume of 3,244,892. The firm's 50-day moving average is $84.06 and its 200-day moving average is $80.48. The company has a market cap of $59.93 billion, a price-to-earnings ratio of 17.45, a PEG ratio of 0.66 and a beta of 1.07. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a 12 month low of $64.61 and a 12 month high of $89.05.
MetLife Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 2.52%. The ex-dividend date is Tuesday, February 4th. MetLife's dividend payout ratio (DPR) is presently 43.95%.
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on MET shares. TD Cowen boosted their target price on MetLife from $97.00 to $99.00 and gave the stock a "buy" rating in a report on Wednesday, November 27th. Barclays upped their price objective on MetLife from $90.00 to $96.00 and gave the stock an "overweight" rating in a report on Monday, January 6th. BMO Capital Markets assumed coverage on shares of MetLife in a research report on Thursday, January 23rd. They set a "market perform" rating and a $97.00 target price for the company. JPMorgan Chase & Co. upped their target price on shares of MetLife from $86.00 to $88.00 and gave the company an "overweight" rating in a research report on Tuesday, January 7th. Finally, Wells Fargo & Company lowered their price objective on shares of MetLife from $93.00 to $92.00 and set an "overweight" rating for the company in a research report on Tuesday, January 14th. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $90.46.
Check Out Our Latest Analysis on MetLife
MetLife Company Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for February 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.